RPI
NBIX icon

Railway Pension Investments’s Neurocrine Biosciences NBIX Stock Holding History

Railway Pension Investments’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,900
Closed -$2.11M – 273
2020
Q3 		$2.11M Buy
21,900
+200
+0.9% +$23.1K 0.02% 256
2020
Q2 		$2.65M Buy
21,700
+500
+2% +$55.3K 0.03% 281
2020
Q1 		$1.83M Buy
21,200
+2,000
+10% +$196K 0.03% 318
2019
Q4 		$2.06M Buy
+19,200
New +$2.01M 0.02% 331

Other funds holding NBIX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Railway Pension Investments's NBIX Position: Q4 2020 in Review

Railway Pension Investments sold out of Neurocrine Biosciences (NBIX) in Q4 2020, closing a stake of 21,900 shares — an estimated $2.11M sold.

Railway Pension Investments first reported a position in NBIX in Q4 2019 and held it in 4 quarters. The position peaked at $2.65M in Q2 2020. 406 funds tracked by Wall St. Rank hold NBIX as of Q4 2020.

  • Railway Pension Investments reported no remaining Neurocrine Biosciences position as of Q4 2020 after selling out during the quarter.
  • Railway Pension Investments sold 21,900 Neurocrine Biosciences shares in Q4 2020, an estimated $2.11M.
  • Railway Pension Investments first reported a position in Neurocrine Biosciences in Q4 2019 and held it in 4 quarters.
  • Railway Pension Investments's Neurocrine Biosciences position peaked at $2.65M in Q2 2020.
  • 406 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q4 2020.

Based on Railway Pension Investments's 13F filing for Q4 2020, filed 8 Feb 2021.